Skip to main content
Fig. 5 | Molecular Cancer

Fig. 5

From: Organoids derived from patients provide a new opportunity for research and individualized treatment of malignant peritoneal mesothelioma

Fig. 5

Analysis of MPM organoids xenotransplantation. A Representative image of subcutaneous xenograft tumor. B The growth curve of subcutaneous xenografts from three different MPM organoids. C The weight comparison of subcutaneous xenografts from three different MPM organoids. D Histologic assessment of parental tumors, MPM organoids, and xenograft tumors in Hematoxylin-eosin (HE) stain. Scale bar (20 μm). E Multiple immuoflurescence staining of cytokeratin 5/6 (CK5/6), Wilms Tumor (WT-1) and calretinin were performed on the parental tumors, MPM organoids, and xenograft tumors. CK5/6, red;WT-1, green;Calretinin, pink. 40X Scale bar (20 μm), 100X Scale bar (10 μm), 200X Scale bar (5 μm), 400X Scale bar (2.5 μm). Data were showed as mean ± SD,Each organoid line was transplanted into three mice

Back to article page

Molecular Cancer

ISSN: 1476-4598